The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Charles Arber und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Induced Pluripotent Stem Cells, Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Society fellowship, Alzheimer's Research UK, EMBO scientific exchange.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Familial Alzheimer's disease (fAD) is heterogeneous in terms of age at onset and clinical presentation. A greater understanding of the pathogenicity of fAD variants and how these contribute to heterogeneity will enhance our understanding of the mechanisms of AD more widely. METHODS To determine the pathogenicity of the unclassified PSEN1 P436S mutation, we studied an expanded kindred of eight affected individuals, with magnetic resonance imaging (MRI) (two individuals), patient‐derived induced pluripotent stem cell (iPSC) models (two donors), and post‐mortem histology (one donor). RESULTS An autosomal dominant pattern of inheritance of fAD was seen, with an average age at symptom onset of 46 years and atypical features. iPSC models and post‐mortem tissue supported high production of amyloid beta 43 (Aβ43). PSEN1 peptide maturation was unimpaired. DISCUSSION We confirm that the P436S mutation in PSEN1 causes atypical fAD. The location of the mutation in the critical PSEN1 proline‐alanine‐leucine‐proline (PALP) motif may explain the early age at onset despite appropriate protein maturation. Highlights PSEN1 P436S mutations cause familial Alzheimer's disease. This mutation is associated with atypical clinical presentation. Induced pluripotent stem cells (iPSCs) and post‐mortem studies support increased amyloid beta (Aβ43) production. Early age at onset highlights the importance of the PALP motif in PSEN1 function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
- Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
- UCL Queen Square Institute of Neurology, UK Dementia Research Institute at UCL, London, UK.
- Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
- Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.
ORCID-Profile: Charles Arber
Förderung
- Alzheimer's Society fellowship
- Alzheimer's Research UK
- EMBO scientific exchange
- The Sigrid Rausing Trust
- Association of Frontotemporal Dementia
- UK Dementia Research Institute
- UK Medical Research Council
- University of London Chadburn Academic Clinical Lectureship
Zitieren
APA
Arber, C., Belder, C. R. S., Tomczuk, F., Gabriele, R., Buhidma, Y., Farrell, C., O'Connor, A., Rice, H., Lashley, T., Fox, N. C., Ryan, N. S., & Wray, S. (2024). The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13904
Vancouver
Arber C, Belder CRS, Tomczuk F, Gabriele R, Buhidma Y, Farrell C, et al. The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13904
BibTeX
@article{Arber2024,
author = {Arber, Charles and Belder, Christopher R S and Tomczuk, Filip and Gabriele, Rebecca and Buhidma, Yazead and Farrell, Clíona and O'Connor, Antoinette and Rice, Helen and Lashley, Tammaryn and Fox, Nick C and Ryan, Natalie S and Wray, Selina},
title = {The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13904}
}
EUVIMED